Study in vitro of the anticancer activity of [3-allyl-4-(4 – methoxyphenyl)-3h-thiazole-2-ylidene]-(3 -trifluoromethylphenyl) amine hydrobromide toward human tumor cells

HIGHLIGHTS

• who: UDC and collaborators from the Medical University have published the research: Study in vitro of the anticancer activity of [3-allyl-4-(4 - methoxyphenyl)-3H-thiazole-2-ylidene]-(3 -trifluoromethylphenyl) amine hydrobromide toward human tumor cells, in the Journal: (JOURNAL)

SUMMARY

[The] Authors showed high inhibitory effects of 3,3`-dimethoxy-N(4),N(4)`-bis(4-(4bromophenyl)thiazol-2-yl)-[1,1`-biphenyl]4,4`-diamine on A549 and C6 cells with the IC50 values of 37.3 μg/mL and 11.3 μg/mL, and low toxicity against NIH-3T3 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.